Invention Grant
- Patent Title: Compositions and processes for targeted delivery, expression and modulation of coding ribonucleic acids in tissue
-
Application No.: US16811504Application Date: 2020-03-06
-
Publication No.: US11359212B2Publication Date: 2022-06-14
- Inventor: Romain Micol , Slawomir Antoszczyk
- Applicant: Combined Therapeutics, Inc.
- Applicant Address: US DE Wilmington
- Assignee: Combined Therapeutics, Inc.
- Current Assignee: Combined Therapeutics, Inc.
- Current Assignee Address: US DE Wilmington
- Agency: DLA Piper LLP (US)
- Priority: GB1714430 20170907
- Main IPC: C12N15/86
- IPC: C12N15/86 ; A61K31/7088 ; A61K35/763 ; A61K45/06 ; A61K48/00

Abstract:
Compositions for expressing a polypeptide within a target organ, the composition comprising a delivery particle, and at least a first mRNA sequence complexed with, encapsulated by, or otherwise associated with the delivery particle, wherein the mRNA sequence comprises at least one coding sequence which codes for at least one polypeptide, at least a first untranslated region (UTR) sequence, and at least one micro-RNA (miRNA) binding site sequence, wherein the miRNA binding site sequence is located within, immediately 5′ to, or immediately 3′ to, the first UTR sequence; and wherein the miRNA binding site sequence provides for differential expression of the coding sequence between first and second cell types comprised within the target organ.
Public/Granted literature
Information query
IPC分类: